================================================================================
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
--------------
SCHEDULE 13G
(Rule 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO
FILED PURSUANT TO RULE 13d-2(b)
(Amendment No. 1)1
HEALTHCORE MEDICAL SOLUTIONS, INC.
-----------------------------------
(Name of Issuer)
Class A Common Stock, par value $.01
------------------------------------
(Title of Class of Securities)
42220B101
--------------
(CUSIP Number)
December 31, 1998
------------------------------------------------------
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
[ ] Rule 13d-1 (b)
[ ] Rule 13d-1 (c)
[x] Rule 13d-1 (d)
- ------------
1 The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
================================================================================
(Continued on following page(s))
Page 1 of 5 Pages
<PAGE>
CUSIP No. 42220B 10 1 13G PAGE 2 OF 5 PAGES
----------- --- ---
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
NEAL J. POLAN ###-##-####
- -----------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) / /
(b) / /
- -----------------------------------------------------------------------
3 SEC USE ONLY
- -----------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
U.S.A.
- -----------------------------------------------------------------------
5 SOLE VOTING POWER
NUMBER OF
SHARES 383,000
------------------------------------------------------
BENEFICIALLY 6 SHARED VOTING POWER
OWNED BY
0
EACH ------------------------------------------------------
REPORTING 7 SOLE DISPOSITIVE POWER
PERSON 383,000
------------------------------------------------------
WITH 8 SHARED DISPOSITIVE POWER
0
- -----------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
383,000
- -----------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES /X/
CERTAIN SHARES*
- -----------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
11.3%
- -----------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
IN
- -----------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
Check the following box if a fee is being paid with this
statement. / /
Item 1(a). Name of Issuer :
----------------
HealthCore Medical Solutions, Inc.
Item 1(b). Address of Issuer's Principal
-----------------------------
Executive Offices:
------------------
11904 Blue Ridge Boulevard
Grandview, Missouri 64030
Item 2(a). Name of Person Filing:
----------------------
Neal J. Polan
Item 2(b). Address of Principal Business Office
------------------------------------
or if none, Residence:
----------------------
1325 Avenue of the Americas
Suite 1200
New York, New York 10019
Item 2(c). Citizenship:
------------
United States
Item 2(d). Title of Class of Securities:
-----------------------------
Class A Common Stock, par value $.01
Item 2(e). CUSIP Number:
-------------
42220B101
Item 3. Not Applicable
Item 4. Ownership:
----------
(a) Amount Beneficially Owned:
383,000 shares
Includes (i) 48,000 shares of Class B Common Stock held by
Mr. Polan as custodian for his child and (ii) 167,000 shares
of Class A Common Stock issuable upon exercise of
outstanding warrants which are exercisable within 60 days.
Excludes 142,000 shares of Class A Common Stock issuable
upon exercise of outstanding warrants which, as of December
31, 1998, were not exercisable within 60 days. Of the shares
of Common Stock held by Mr. Polan, 216,000 of the shares are
shares of Class B Common Stock which are entitled to five
votes per share and are convertible into shares of Class A
Common Stock under certain circumstances.
(b) Percent of Class: 11.3
Page 3 of 5 pages
<PAGE>
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote:
383,000
(ii) shared power to vote or to direct the vote:
0
(iii) sole power to dispose or to direct the
disposition of:
383,000
(iv) shared power to dispose or to direct the
disposition of:
0
Item 5. Ownership of Five Percent or Less of a Class
--------------------------------------------
Not Applicable
Item 6. Ownership of More than Five Percent on Behalf of
------------------------------------------------
Another Person
---------------
Not Applicable
Item 7. Identification and Classification of the
----------------------------------------
Subsidiary Which Acquired the Securities
----------------------------------------
Not Applicable
Item 8. Identification and Classification of Members
--------------------------------------------
of the Group
------------
Not Applicable
Item 9. Notice of Dissolution of Group
------------------------------
Not Applicable
Item 10. Certification
-------------
Not Applicable
Page 4 of 5 pages
<PAGE>
Signature
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
February 16, 1999
- ---------------------------------
Date
/s/ NEAL J. POLAN
- ---------------------------------
Signature
Neal J. Polan
- ---------------------------------
Name/Title
Page 5 of 5 pages
